Ndung’u Lab
Immune mechanisms of HIV control
Lab Overview
The Ndung’u Lab studies host-pathogen interactions, particularly antiviral immune responses associated with protection against or control of HIV infection. Our research focuses on harnessing antiviral immune responses for HIV vaccine development or cure, the implications of HIV diversity for epidemic spread, pathogenesis, immune control, and the impact of HIV infection on anti-tuberculosis immune control mechanisms.
HIV Pathogenesis ProgrammeAHRI WebsiteNdung'u's profile at AHRIThumbi Ndung’u, PhD
Principal Investigator
About
Dr. Ndung’u was awarded the Edgar Haber Award (Harvard University), the Vice-Chancellor’s Research Award, University of KwaZulu-Natal, the Friedland Senior Health Researcher Prize-University of the Witwatersrand, South Africa, and the South African Medical Research Council Gold Scientific Achievement Award. He has also received the Research Excellence Award at the South African Health Excellence Awards.
Recognition & Honors
- Member of the Academy of Science of South Africa, and a Fellow of the African Academy of Sciences
- Recipient of the South African Medical Research Gold Medal award for seminal contributions to health research.
Looking for Collaboration?
Contact UsSelected Publications
Construction and Analysis of an Infectious Human Immunodeficiency Virus Type 1 Subtype C Molecular Clone
Journal of Virology 2001 Jun;75(11):4964-72. PMID: 11333875
Gag-Protease-Mediated Replication Capacity in HIV-1 Subtype C Chronic Infection: Associations with HLA Type and Clinical Parameters
Journal of Virology 2010 Oct;84(20):10820-31. doi: 10.1128/JVI.01084-10. Epub 2010 Aug 11. PMID: 20702636
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes
Retrovirology 2013 Sep 16;10:100. doi: 10.1186/1742-4690-10-100. PMID: 24041011
Selection bias at the heterosexual HIV-1 transmission bottleneck
Science 2014 Jul 11;345(6193):1254031. doi: 10.1126/science.1254031. Epub 2014 Jul 10. PMID: 25013080
Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity are Consistent with Inter-Subtype Differences in HIV-1 Disease Progression
Journal of Virology 2017 Jun 9;91(13). pii: e00253-17. doi: 10.1128/JVI.00253-17. Print 2017 Jul 1. PMID: 28424286
CD8+ T cell breadth and ex vivo virus inhibition capacity distinguish between viremic controllers with and without protective HLA class I alleles
Journal of Virology 2016 Jul 11;90(15):6818-31. doi: 10.1128/JVI.00276-16. Print 2016 Aug 1. PMID: 27194762
Why and where an HIV cure is needed and how it might be achieved
Nature 2019 Dec;576(7787):397-405. doi: 10.1038/s41586-019-1841-8. Epub 2019 Dec 18. Review. PMID: 31853080
Association between the cytokine storm, immune cell dynamics and viral replicative capacity in hyperacute HIV infection
BMC Medicine 2020 Mar 25;18(1):81. doi: 10.1186/s12916-020-01529-6. PMID: 32209092